K2M’s President and CEO Eric Major noted in the report, “FDA clearance of MESA 2 is a milestone event for K2M that further enhances our position in the global spine surgery market.” The MESA 2 is the next generation of the company’s established MESA spinal device.
To learn more about K2M and their wide variety of medical devices, click here.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
